Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in:

• individuals 65 years of age and older;
• individuals 18 through 64 years of age at high risk of severe COVID-19; and
• individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19.
  Today’s authorization applies only to the Pfizer-BioNTech COVID-19 Vaccine.

“Today’s action demonstrates that science and the currently available data continue to guide the FDA’s decision-making for COVID-19 vaccines during this pandemic. After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others,” said Acting FDA Commissioner Janet Woodcock, M.D. “This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed.”

[Full FDA Press Release]

Killing Fields refer to places where mass killings have occurred either during war or even by serial killers. With more deaths being reported to VAERS from the Covid-19 ‘vaccine’ than all other vaccines in the last thirty years combined, it has become clear we have created a medical killing field. What’s worse, it is known that systems like VAERS only capture about 1% of the adverse effects actually being experienced in the general public. In this video, Dr. Robert Malone, Inventor Of The mRNA ‘Vaccine’ Technology, Dr. Maria Gonzales, U.S. Department of Health & Jodi O’Malley, R.N., U.S. Department of Health discuss and comment on the Covid-19 ‘vaccine’ adverse effects.

Researchers: Priyamadhaba Behera ¹, Binod Kumar Patro ¹, Arvind Kumar Singh ¹, Pradnya Dilip Chandanshive ¹, Ravikumar S R ¹, Somen Kumar Pradhan ¹, Siva Santosh Kumar Pentapati ¹, Gitanjali Batmanabane ², Prasanta Raghab Mohapatra ³, Biswa Mohan Padhy ⁴, Shakti Kumar Bal ³, Sudipta Ranjan Singh ⁵, Rashmi Ranjan Mohanty ⁶

Background: Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in SARS-CoV-2 infection. The study was aimed to explore the association between ivermectin prophylaxis and the development of SARS-CoV-2 infection among healthcare workers.

Conclusion: Two-dose ivermectin prophylaxis at a dose of 300 μg/kg with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among healthcare workers for the following month. Chemoprophylaxis has relevance in the containment of pandemic.

[National Institutes of Health]

Published: 05th November 2020 12:55 AM  |   Last Updated: 05th November 2020 12:55 AM

BHUBANESWAR: In a significant finding, two-dose Ivermectin prophylaxis has led to 73 per cent
reduction in COVID-19 infection among healthcare workers (HCWs), who are more likely to contract the virus given their nature of job.

“Earlier, at least 20 to 25 HCWs were getting infected with the virus daily. After the workers started taking Ivermectin, the number of infection has come down to one or two per day,” Dr Batmanabane said.

“Considering the fact that Ivermectin had been shown to have diverse mechanisms by which it successfully attacks the SARS-CoV-2, we decided to use it. The Ivermectin has a proven safety profile as a safe drug which has been used for many decades. The encouraging results of a study from Egypt prompted us to explore its role as prophylaxis for HCWs,” she said. . . .

[New India Express]

Following an intense daylong public discussion, a panel of scientific advisors to the U.S. Food and Drug Administration (FDA) today voted 16 to 2 against recommending a third shot of Pfizer’s COVID vaccine for people 16 and older.

The Biden administration has been hoping the FDA would approve a third shot of the Pfizer vaccine in time to begin rolling out boosters for Pfizer recipients next week, the New York Times reported.

The vote came after a sharp debate in which many of the panel’s independent experts, including infectious disease doctors and statisticians, challenged whether the data justified a broad rollout of extra shots when the vaccines appear to still offer robust protection against severe COVID-19 disease and hospitalization, at least in the U.S.

“It’s unclear that everyone needs to be boosted, other than a subset of the population that clearly would be at high risk for serious disease,” said Dr. Michael G. Kurilla, a committee member and official at the National Institutes of Health.

The issue of whether or not to approve boosters has become increasingly contentious, dividing scientists, both outside and inside the FDA, including two scientists who recently announced they are leaving the agency because of pressure from the Biden administration to approve boosters, citing the lack of data to support a third shot.

“It’s a welcome sight to see actual deliberations in meetings about vaccine booster shots at the FDA,” said Mary Holland, president of Children’s Health Defense. “It’s encouraging that a panel of experts stood up to political and corporate pressure based on the lack of convincing data for safety and efficacy of boosters.”

Holland added:

“One can only hope the FDA and Centers for Disease Control and Prevention panels will continue to engage in vigorous debate about vaccine science and medicine.”

As The Hill reported, the advisory panel’s vote is not binding, so the FDA doesn’t have to accept the results. But if the agency doesn’t, it will raise significant questions of political interference and pit agency scientists against political officials who signed off on the booster plan.

In an unusual move last month, Biden and top health officials, including Surgeon General Vicek Murthy, acting FDA Commissioner Dr. Janet Woodcock and CDC  Director Dr, Rochelle Walensky, publicly announced a booster shot program would begin the week of Sept. 20, well before the FDA and CDC examined the evidence.

On Thursday, FDA scientists had expressed skepticism about the need for Pfizer COVID vaccine booster shots in a report released Wednesday.

In 23-page report, FDA officials said, based on their analysis of data submitted by Pfizer and BioNTech, they could not yet take a stance on whether to recommend COVID boosters for the general public.

SIGN UP #TheDefender: https://t.co/zL66Edfiw5https://t.co/dvbbGv87R2

— Robert F. Kennedy Jr (@RobertKennedyJr) September 16, 2021

The 23-page report analyzed data submitted by Pfizer and BioNTech as part of the drugmakers’ request for authorization for their vaccine to be given as a booster shot in people 16 years and older.

[Children’s Health Defense]

As of September 2021, the standard protocol for Covid-19 patients is still to be sent home and when their lips turn blue from low oxygen, they are hospitalized. Knowing they’re at risk of being hospitalized Americans are desperately seeking for some sort of treatment.

Dr. Malone discusses the bizarre amount of misinformation that is being spread about perfectly safe and useful medications, such as the Nobel Prize winning drug for human use, Ivermectin.

What ever happened to the Liberal cry that government should not come between a patient and her doctor?